arrow
A

Andrew D. Mesecar

Purdue University
H指数:66
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design; synthesis; and X-ray structural studies of potent SARS-CoV-2 Mpro inhibitors containing tetrahydroisoquinoline-3-carboxamides as P2 ligands

设计、合成及X射线结构研究含有四氢异喹啉-3-甲酰胺作为P2配体的强效SARS-CoV-2 Mpro抑制剂

2026-07-240
OAAI
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer’s Disease Models

SHIP1配体在阿尔茨海默病模型中针对细胞靶点的结合与活性优化及表征

2026-04-300
PRE
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease
2023-11-175
OAAI
Genetic variants of phospholipase C-g2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease
IMMUNITY
IF26.3
2023-09-0110
OA
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
2021-10-18204
OAAI
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors

非甾体抗炎药和相关衍生物的氯代吡啶基酯作为有效的SARS-CoV-2 3CL蛋白酶抑制剂

2021-09-2411
OAAI
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

美国国立卫生研究院SARS-CoV-2抗病毒治疗峰会的报告

2021-06-1025
OAAI
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
2021-01-28136
OAAI